Zydus Lifesciences Sentynl Therapeutics Licenses Progerinin for Hutchinson-Gilford Progeria Syndrome Treatment
Zydus Lifesciences subsidiary, Sentynl Therapeutics, has entered an agreement with Korea’s PRG S&T to license the investigational…